Indications & Dose:
Adults : •
• BY MOUTH
Dysfunctional uterine bleeding;,
200 mg daily for 3 months. Start on 1st day of menstrutation and continue without interruption
Children : Not recommended
• Fibrocystic breast disease:
• BY MOUTH
Initially 300mg daily for 3-6 months
• Mastalgia:
• BY MOUTH
100-400 mg daily for 6 months
• Gynaecomastia:
• BY MOUTH
400 mg daily for 6 months
Children, 200mg daily for 6 months, if no response after 2 months increase to 400mg daily
. • Endometrriosis;
• BY MOUTH
Start on 1st day of menstrutation and continue without interruption, 200-800mg daily for 6-9 months. Prior to ablation, 400-800mg daily for 3-6 weeks
Children: Not recommended.
Contraindications:
Side Effects:
CNS: Dizziness, emotional lability, fatigue, headache, nervousness, sleep disorders, tremor
CV: Elevated blood pressure
GI: Constipation, hepatic dysfunction (doses >400 mg/day), nausea, vomiting, pancreatitis
GU: Clitoral hypertrophy, hematuria, pelvic pain, testicular atrophy, menstrual irregularities (spotting, amenorrhea; cycle disturbances), vaginal dryness
METAB: Decreased HDL, increased LDL
SKIN: Acne, edema, flushing, mild hirsutism, oily skin or hair, sweating
MISC: Changes in libido, decrease in breast size, deepening of the voice, glucose intolerance, weight gain
Cautions:
Precautions:
Interaction:
Drugs
Carbamazepine: Predictably increases serum carbamazepine concentrations, toxicity possible
Cyclosporine: Increased serum cyclosporine concentrations, toxicity possible
HMG-CoA reductase inhibitors (lovastatin, pravastatin): Myositisrisk increased
Oral anticoagulants: Enhanced hypoprothrombinemic response
Tacrolimus: Increased tacrolimus concentrations, toxicity possible
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team